Alexander Douglass
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alexander Douglass has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Catherine M. Phillips
School of Public Health, Physiotherapy and Sports Science, University College Dublin, Belfield, Dublin 4, Ireland
3 shared publications - Adrien M. Aubert
School of Public Health, Physiotherapy and Sports Science University College Dublin Dublin Ireland
2 shared publications - Fionnuala M. McAuliffe
UCD Perinatal Research Centre, School of Medicine, University College Dublin, National Maternity Hospital, Dublin, Ireland
2 shared publications - Aisling Y. Coughlan
UCD Conway Institute, School of Medicine, University College Dublin, Dublin, Ireland
1 shared publication - Alexandre Martos
UCD Conway Institute, School of Medicine, University College Dublin, Dublin, Ireland
1 shared publication - Barbara Heude
Université Paris Cité and Université Sorbonne Paris Nord, Inserm, INRAE, Center for Research in Epidemiology and StatisticS (CRESS), Paris, France
1 shared publication
Latest Publications
- Open Access
- 2 September 2026
- Published by Elsevier in Nutrition, Metabolism and Cardiovascular Diseases
Maternal healthy lifestyle during pregnancy and offspring metabolic health phenotypes in childhood
- 2 September 2026
- Published by Elsevier in Nutrition, Metabolism and Cardiovascular Diseases
Open AccessMaternal healthy lifestyle during pregnancy and offspring metabolic health phenotypes in childhood
- Open Access
- 16 January 2025
- Published by Wiley in British Journal of Health Psychology
- Vol. 30 (1) , e12776
Associations between lifestyle and well‐being in early and late pregnancy in women with overweight or obesity: Secondary analyses of the PEARS RCT
Objectives: The associations between individual lifestyle behaviours and well‐being are still poorly understood, particularly in the antenatal period when women are exposed to physiological changes and increased psychological distress. A healthy lifestyle score (HLS) comprising protective lifestyle behaviours may be useful for studying links between overall lifestyle and psychosocial outcomes. This study aimed to examine bidirectional associations between a HLS and its components and psychological well‐being in pregnant women with overweight/obesity. Design: Secondary analyses of data from the PEARS trial. Methods: Healthy lifestyle scores (scored 0–5) based on maternal diet (AHEI‐P), physical activity (MET‐minutes), alcohol consumption, smoking, and sleep habits were created for 330 and 287 mothers with overweight/obesity in early (14–16 weeks gestation) and late pregnancy (28 weeks gestation), respectively. Psychological well‐being was measured with the WHO‐5 well‐being index. Cross‐lagged path models (crude/adjusted) tested the directionality of relationships between lifestyle (composite score/individual components) and well‐being cross‐sectionally and over time in pregnancy. Results: The mean early pregnancy BMI was 29.2 kg/m 2 . The mean well‐being score was 56.3% in early and 60.7% in late pregnancy. Significant autoregressive effects were observed for the HLS, all individual components, and well‐being from early to late pregnancy. Well‐being was positively correlated with the HLS, physical activity, and sleep variables within time points (in early and/or late pregnancy). Sleep and no smoking in early pregnancy predicted higher well‐being in late pregnancy. Conclusions: Overall healthy lifestyle, physical activity, and especially sleep duration and quality are associated with psychological well‐being in pregnancy, and should be promoted antenatally.
- 16 January 2025
- Published by Wiley in British Journal of Health Psychology
- Vol. 30 (1) , e12776
Open AccessAssociations between lifestyle and well‐being in early and late pregnancy in women with overweight or obesity: Secondary analyses of the PEARS RCT
Objectives: The associations between individual lifestyle behaviours and well‐being are still poorly understood, particularly in the antenatal period when women are exposed to physiological changes and increased psychological distress. A healthy lifestyle score (HLS) comprising protective lifestyle behaviours may be useful for studying links between overall lifestyle and psychosocial outcomes. This study aimed to examine bidirectional associations between a HLS and its components and psychological well‐being in pregnant women with overweight/obesity. Design: Secondary analyses of data from the PEARS trial. Methods: Healthy lifestyle scores (scored 0–5) based on maternal diet (AHEI‐P), physical activity (MET‐minutes), alcohol consumption, smoking, and sleep habits were created for 330 and 287 mothers with overweight/obesity in early (14–16 weeks gestation) and late pregnancy (28 weeks gestation), respectively. Psychological well‐being was measured with the WHO‐5 well‐being index. Cross‐lagged path models (crude/adjusted) tested the directionality of relationships between lifestyle (composite score/individual components) and well‐being cross‐sectionally and over time in pregnancy. Results: The mean early pregnancy BMI was 29.2 kg/m 2 . The mean well‐being score was 56.3% in early and 60.7% in late pregnancy. Significant autoregressive effects were observed for the HLS, all individual components, and well‐being from early to late pregnancy. Well‐being was positively correlated with the HLS, physical activity, and sleep variables within time points (in early and/or late pregnancy). Sleep and no smoking in early pregnancy predicted higher well‐being in late pregnancy. Conclusions: Overall healthy lifestyle, physical activity, and especially sleep duration and quality are associated with psychological well‐being in pregnancy, and should be promoted antenatally.
- Open Access
Associations between a paternal healthy lifestyle score and its individual components with childhood overweight and obesity
Background: Maternal healthy lifestyle behaviors during pregnancy have been associated with reduced risk of offspring overweight and obesity (OWOB). However, there has been little investigation, in the context of the Paternal Origins of Health and Disease (POHaD) paradigm, of the potential influence of the paternal lifestyle on offspring OWOB.Objectives: To describe paternal healthy lifestyle factors around pregnancy and investigate their associations, individually and combined, with offspring risk of OWOB during childhood.Materials and methods: Participants included 295 father–child pairs from the Lifeways Cross‐Generation Cohort Study. A composite paternal healthy lifestyle score (HLS) based on having a high dietary quality (top 40% of the Healthy Eating Index‐2015), meeting physical activity guidelines (≥450 MET‐min/week of moderate‐to‐vigorous physical activity), having a healthy body mass index (BMI) (18.5–24.9 kg/m2), being a non‐smoker, and having no/moderate alcohol intake, was calculated (range 0–5). Paternal HLS (and individual components) associations with child BMI and waist‐to‐height ratio (WHtR) at age 5 and 9 years were assessed using linear (BMI z‐scores and WHtR) and logistic (IOTF categories) regression analyses, adjusted for sociodemographic characteristics.Results: At age 5 and 9 years, 23.5% and 16.9% of children were classified as living with OWOB, respectively. Of the 160 pairs with a complete HLS, 45.0% of the fathers had unfavorable lifestyle factors, determined by a low HLS between 0 and 2 points. Although a low paternal HLS was not significantly associated with a higher risk of childhood OWOB measured using either BMI z‐scores and IOTF categories, it was associated with a greater child WHtR, an indicator of central adiposity, at 9 years of age (β [95% CI] = 0.04 [0.01,0.07]).Discussion and conclusion: Almost half of the fathers had unfavorable lifestyle factors around pregnancy. A low paternal HLS was associated with a greater child WHtR at 9 years but not with a higher risk of childhood OWOB when measured by BMI z‐scores or IOTF categories.
Open AccessAssociations between a paternal healthy lifestyle score and its individual components with childhood overweight and obesity
Background: Maternal healthy lifestyle behaviors during pregnancy have been associated with reduced risk of offspring overweight and obesity (OWOB). However, there has been little investigation, in the context of the Paternal Origins of Health and Disease (POHaD) paradigm, of the potential influence of the paternal lifestyle on offspring OWOB.Objectives: To describe paternal healthy lifestyle factors around pregnancy and investigate their associations, individually and combined, with offspring risk of OWOB during childhood.Materials and methods: Participants included 295 father–child pairs from the Lifeways Cross‐Generation Cohort Study. A composite paternal healthy lifestyle score (HLS) based on having a high dietary quality (top 40% of the Healthy Eating Index‐2015), meeting physical activity guidelines (≥450 MET‐min/week of moderate‐to‐vigorous physical activity), having a healthy body mass index (BMI) (18.5–24.9 kg/m2), being a non‐smoker, and having no/moderate alcohol intake, was calculated (range 0–5). Paternal HLS (and individual components) associations with child BMI and waist‐to‐height ratio (WHtR) at age 5 and 9 years were assessed using linear (BMI z‐scores and WHtR) and logistic (IOTF categories) regression analyses, adjusted for sociodemographic characteristics.Results: At age 5 and 9 years, 23.5% and 16.9% of children were classified as living with OWOB, respectively. Of the 160 pairs with a complete HLS, 45.0% of the fathers had unfavorable lifestyle factors, determined by a low HLS between 0 and 2 points. Although a low paternal HLS was not significantly associated with a higher risk of childhood OWOB measured using either BMI z‐scores and IOTF categories, it was associated with a greater child WHtR, an indicator of central adiposity, at 9 years of age (β [95% CI] = 0.04 [0.01,0.07]).Discussion and conclusion: Almost half of the fathers had unfavorable lifestyle factors around pregnancy. A low paternal HLS was associated with a greater child WHtR at 9 years but not with a higher risk of childhood OWOB when measured by BMI z‐scores or IOTF categories.
- Open Access
- 19 July 2018
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 14 (7) , e1007138
Population genomics shows no distinction between pathogenic Candida krusei and environmental Pichia kudriavzevii: One species, four names
We investigated genomic diversity of a yeast species that is both an opportunistic pathogen and an important industrial yeast. Under the name Candida krusei, it is responsible for about 2% of yeast infections caused by Candida species in humans. Bloodstream infections with C. krusei are problematic because most isolates are fluconazole-resistant. Under the names Pichia kudriavzevii, Issatchenkia orientalis and Candida glycerinogenes, the same yeast, including genetically modified strains, is used for industrial-scale production of glycerol and succinate. It is also used to make some fermented foods. Here, we sequenced the type strains of C. krusei (CBS573T) and P. kudriavzevii (CBS5147T), as well as 30 other clinical and environmental isolates. Our results show conclusively that they are the same species, with collinear genomes 99.6% identical in DNA sequence. Phylogenetic analysis of SNPs does not segregate clinical and environmental isolates into separate clades, suggesting that C. krusei infections are frequently acquired from the environment. Reduced resistance of strains to fluconazole correlates with the presence of one gene instead of two at the ABC11-ABC1 tandem locus. Most isolates are diploid, but one-quarter are triploid. Loss of heterozygosity is common, including at the mating-type locus. Our PacBio/Illumina assembly of the 10.8 Mb CBS573T genome is resolved into 5 complete chromosomes, and was annotated using RNAseq support. Each of the 5 centromeres is a 35 kb gene desert containing a large inverted repeat. This species is a member of the genus Pichia and family Pichiaceae (the methylotrophic yeasts clade), and so is only distantly related to other pathogenic Candida species. Infections with yeasts resistant to antifungal drugs are an increasing cause of concern. One species, Candida krusei, has innate resistance to the widely-used drug fluconazole. It is one of the five most prevalent causes of clinical yeast infections, and is responsible for significant levels of morbidity and mortality in immunocompromised patients. In this study, we show that C. krusei is the same species as Pichia kudriavzevii, a yeast that is regarded as non-pathogenic and has important applications in biotechnology and food industries. We examined the genomes of 20 clinical isolates (‘C. krusei’) and 12 environmental isolates (‘P. kudriavzevii’) and find that there is no genetic distinction between them. The environmental isolates have similar levels of drug resistance to the clinical isolates. As well as providing a resource for future studies of this yeast, our results indicate that caution may be needed in the use of drug-resistant P. kudriavzevii strains for biotechnology and food applications.
- 19 July 2018
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 14 (7) , e1007138
Open AccessPopulation genomics shows no distinction between pathogenic Candida krusei and environmental Pichia kudriavzevii: One species, four names
We investigated genomic diversity of a yeast species that is both an opportunistic pathogen and an important industrial yeast. Under the name Candida krusei, it is responsible for about 2% of yeast infections caused by Candida species in humans. Bloodstream infections with C. krusei are problematic because most isolates are fluconazole-resistant. Under the names Pichia kudriavzevii, Issatchenkia orientalis and Candida glycerinogenes, the same yeast, including genetically modified strains, is used for industrial-scale production of glycerol and succinate. It is also used to make some fermented foods. Here, we sequenced the type strains of C. krusei (CBS573T) and P. kudriavzevii (CBS5147T), as well as 30 other clinical and environmental isolates. Our results show conclusively that they are the same species, with collinear genomes 99.6% identical in DNA sequence. Phylogenetic analysis of SNPs does not segregate clinical and environmental isolates into separate clades, suggesting that C. krusei infections are frequently acquired from the environment. Reduced resistance of strains to fluconazole correlates with the presence of one gene instead of two at the ABC11-ABC1 tandem locus. Most isolates are diploid, but one-quarter are triploid. Loss of heterozygosity is common, including at the mating-type locus. Our PacBio/Illumina assembly of the 10.8 Mb CBS573T genome is resolved into 5 complete chromosomes, and was annotated using RNAseq support. Each of the 5 centromeres is a 35 kb gene desert containing a large inverted repeat. This species is a member of the genus Pichia and family Pichiaceae (the methylotrophic yeasts clade), and so is only distantly related to other pathogenic Candida species. Infections with yeasts resistant to antifungal drugs are an increasing cause of concern. One species, Candida krusei, has innate resistance to the widely-used drug fluconazole. It is one of the five most prevalent causes of clinical yeast infections, and is responsible for significant levels of morbidity and mortality in immunocompromised patients. In this study, we show that C. krusei is the same species as Pichia kudriavzevii, a yeast that is regarded as non-pathogenic and has important applications in biotechnology and food industries. We examined the genomes of 20 clinical isolates (‘C. krusei’) and 12 environmental isolates (‘P. kudriavzevii’) and find that there is no genetic distinction between them. The environmental isolates have similar levels of drug resistance to the clinical isolates. As well as providing a resource for future studies of this yeast, our results indicate that caution may be needed in the use of drug-resistant P. kudriavzevii strains for biotechnology and food applications.